Library
On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.
What is Harm Reduction?
Open Society Foundation give a great explainer of harm reduction, stating that it is a multi-faceted and the importance of changing drug policy.
Open Society Foundation give a great explainer of harm reduction, stating that it is a multi-faceted and the importance of changing drug policy.
Hepatitis Scotland e-Bulletin: A Treatment Focus
Hepatitis Scotland review recent treatment news, including research presented at the 64th Annual Meeting of the American Association for the Study of the Liver in Washington D.C, along with other stories relevant to the treatment of viral hepatitis. Highlighting a way forward without inteferon but looks like the cost will exclude 90% of people who need them.
Hepatitis Scotland review recent treatment news, including research presented at the 64th Annual Meeting of the American Association for the Study of the Liver in Washington D.C, along with other stories relevant to the treatment of viral hepatitis. Highlighting a way forward without inteferon but looks like the cost will exclude 90% of people who need them.
Palliative care – a human right
The European Association for Palliative Care, the International Association for Hospice and Palliative care, the Worldwide Palliative Care Alliance and the Human Rights Watch, urge governments to relieve suffering and recognize palliative care as a human right. The briefing gives and definition of palliative care and state what the groups would like governments to recognize the need for access to palliative care.
The European Association for Palliative Care, the International Association for Hospice and Palliative care, the Worldwide Palliative Care Alliance and the Human Rights Watch, urge governments to relieve suffering and recognize palliative care as a human right. The briefing gives and definition of palliative care and state what the groups would like governments to recognize the need for access to palliative care.
The war in Syria and the drug bomb
Dr. Ghassan Shahrour presentation at the MENA 2nd Conference held in Beirut November 2013 which discussed the regional drug maps.
Dr. Ghassan Shahrour presentation at the MENA 2nd Conference held in Beirut November 2013 which discussed the regional drug maps.
21–22 November 2013, Tallinn
Reitox Academy for Baltic countries: Monitoring trends in and responses to drug-related infectious diseases among people who inject drugs
Reitox Academy for Baltic countries: Monitoring trends in and responses to drug-related infectious diseases among people who inject drugs
Annals of Oncology
Read ground-breaking international collaborative survey, published in Annals of Oncology, shows that more than half of the world’s population live in countries where regulations that aim to stem drug misuse leave cancer patients without access to opioid medicines for managing cancer pain. The GOPI study has uncovered a pandemic of over-regulation in much of the developing world that is making it catastrophically difficult to provide basic medication to relieve strong cancer pain,”
Read ground-breaking international collaborative survey, published in Annals of Oncology, shows that more than half of the world’s population live in countries where regulations that aim to stem drug misuse leave cancer patients without access to opioid medicines for managing cancer pain. The GOPI study has uncovered a pandemic of over-regulation in much of the developing world that is making it catastrophically difficult to provide basic medication to relieve strong cancer pain,”
Drug policy advocacy in Asia: Challenges, opportunities and prospects
International Drug Policy Consortium (IDPC), produced this report to develop a better understanding of drug policy advocacy activity in 10 Asian countries: Cambodia, China, India, Indonesia, Lao PDR, Malaysia, Myanmar, the Philippines, Thailand, and Vietnam. It aims to achieve three goals: 1; Identify organisations engaged in harm reduction and drug policy advocacy, 2;Identify gaps and challenges in harm reduction and drug policy advocacy that remain to be addressed, 3; Develop recommendations for prioritising new activities in harm reduction and drug policy advocacy.
International Drug Policy Consortium (IDPC), produced this report to develop a better understanding of drug policy advocacy activity in 10 Asian countries: Cambodia, China, India, Indonesia, Lao PDR, Malaysia, Myanmar, the Philippines, Thailand, and Vietnam. It aims to achieve three goals: 1; Identify organisations engaged in harm reduction and drug policy advocacy, 2;Identify gaps and challenges in harm reduction and drug policy advocacy that remain to be addressed, 3; Develop recommendations for prioritising new activities in harm reduction and drug policy advocacy.
Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders
This quick guide for clinicians provides succinct, easily accessible information to clinicians about the use of medications to help patients with substance use disorders (SUDs) deal with chronic noncancer pain (CNCP). The guide includes information on 1)patient assessment; 2)chronic pain management; 3)patients treated with opioids; and 4)treatment agreements.
This quick guide for clinicians provides succinct, easily accessible information to clinicians about the use of medications to help patients with substance use disorders (SUDs) deal with chronic noncancer pain (CNCP). The guide includes information on 1)patient assessment; 2)chronic pain management; 3)patients treated with opioids; and 4)treatment agreements.
Patterns and Trends of Amphetamine-Type Stimulants and Other Drugs: Challenges for Asia and the Pacific 2013
Global Synthetics Monitoring: Analyses, Reporting and Trends (SMART) Programme highlights the most current patterns and trends of amphetamine-type stimulants and other drugs of use in East and Southeast Asia and provides overviews for the neighbouring regions of South Asia and the Pacific Island States and Territories. From all 15 countries that contributed to this report, 13 countries reported methamphetamine as the primary or secondary drug of use.
Global Synthetics Monitoring: Analyses, Reporting and Trends (SMART) Programme highlights the most current patterns and trends of amphetamine-type stimulants and other drugs of use in East and Southeast Asia and provides overviews for the neighbouring regions of South Asia and the Pacific Island States and Territories. From all 15 countries that contributed to this report, 13 countries reported methamphetamine as the primary or secondary drug of use.
International AIDS Society News October 2013
IAS give an update on their current activities including the 2013 Kuala Lumpur conference and the upcoming conference in Melbourne 2014.
IAS give an update on their current activities including the 2013 Kuala Lumpur conference and the upcoming conference in Melbourne 2014.
